PHI-101
PHI-101 is an orally active, potent third-generation inhibitor of FLT3 that overcomes resistance to multiple drug-resistant mutations. It has potential for research in relapsed or refractory acute myeloid leukemia (AML).
| Catalog Number | E1437 |
| Molecular Formula | C22H12ClF3N2O4 |
| CAS# | 2127107-15-5 |
| Size | 1g |
| Supplier Page | http://www.selleckchem.com/products/phi-101.html |
| Additional Information | https://file.selleck.cn/downloads/struct/E1437-PHI-101-chemical-structure.png |